Thymidine kinase 1 (TK1) is a tumor marker for the diagnosis of hepatocellular carcinoma (HCC).
Alpha-fetoprotein (AFP) was not detected in 25% of the HCC patients in our study.
The combined analysis of AFP, TKI and alpha-l-fucosidase could improve the sensitivity of HCC diagnosis.